[go: up one dir, main page]

MX2015007494A - Metodo para diagnosticar leucodistrofia metacromatica. - Google Patents

Metodo para diagnosticar leucodistrofia metacromatica.

Info

Publication number
MX2015007494A
MX2015007494A MX2015007494A MX2015007494A MX2015007494A MX 2015007494 A MX2015007494 A MX 2015007494A MX 2015007494 A MX2015007494 A MX 2015007494A MX 2015007494 A MX2015007494 A MX 2015007494A MX 2015007494 A MX2015007494 A MX 2015007494A
Authority
MX
Mexico
Prior art keywords
metachromatic leukodystrophy
diagnosis
biomarker
sample
subject
Prior art date
Application number
MX2015007494A
Other languages
English (en)
Inventor
Arndt Rolfs
Hermann Mascher
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12008293.8A external-priority patent/EP2743700A1/en
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of MX2015007494A publication Critical patent/MX2015007494A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

La presente invención se refiere a un método para diagnosticar leucodistrofia metacromática en un sujeto, que comprende el paso a), en donde el paso a) comprende detectar un biomarcador en una muestra del sujeto, en donde la muestra se selecciona entre el grupo que consiste de sangre, sangre seca, suero y plasma y en donde el biomarcador es diferente de una enzima.
MX2015007494A 2012-12-11 2013-12-11 Metodo para diagnosticar leucodistrofia metacromatica. MX2015007494A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12008257 2012-12-11
EP12008293.8A EP2743700A1 (en) 2012-12-12 2012-12-12 Method for the diagnosis of metachromatic leukodystrophy
EP13001454 2013-03-21
PCT/EP2013/003750 WO2014090404A1 (en) 2012-12-11 2013-12-11 Method for the diagnosis of metachromatic leukodystrophy

Publications (1)

Publication Number Publication Date
MX2015007494A true MX2015007494A (es) 2015-12-15

Family

ID=49911451

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007494A MX2015007494A (es) 2012-12-11 2013-12-11 Metodo para diagnosticar leucodistrofia metacromatica.

Country Status (9)

Country Link
US (2) US10690682B2 (es)
EP (1) EP2932274B1 (es)
JP (1) JP2016506501A (es)
AU (1) AU2013357812B2 (es)
BR (1) BR112015013498A2 (es)
CA (1) CA2893609A1 (es)
IL (1) IL239117B (es)
MX (1) MX2015007494A (es)
WO (1) WO2014090404A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017066780A1 (en) * 2015-10-16 2017-04-20 University Of Washington Sulfatide analysis for newborn screening and diagnosis of metachromatic leukodystrophy
WO2019185738A1 (en) * 2018-03-27 2019-10-03 Universiteit Maastricht Method for the diagnosis of biliary tract diseases
JP7599867B2 (ja) * 2019-08-23 2024-12-16 Ｊｃｒファーマ株式会社 脳脊髄液に含まれるＨｅｘ４，ｌｙｓｏ－ＧＭ１，Ｆｕｃ－ＧｌｃＮＡｃ－Ａｓｎ，及びｌｙｓｏ－ｓｕｌｆａｔｉｄｅの定量法
RU2769577C1 (ru) * 2021-06-01 2022-04-04 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Препарат для лечения метахроматической лейкодистрофии и способ ее лечения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1461611B1 (en) * 2001-12-10 2010-03-03 Washington University Diagnostic for early stage alzheimer's disease
PT2628746T (pt) * 2006-04-04 2019-04-23 Chiesi Farm Spa Um processo para a concentração de um polipéptido
WO2012081508A1 (ja) * 2010-12-13 2012-06-21 日本ケミカルリサーチ株式会社 スフィンゴ糖脂質の定量法
EP2533051A1 (en) * 2011-06-06 2012-12-12 Centogene GmbH Method for the diagnosis of Gaucher's disease
EP2743700A1 (en) * 2012-12-12 2014-06-18 Centogene GmbH Method for the diagnosis of metachromatic leukodystrophy

Also Published As

Publication number Publication date
IL239117B (en) 2018-01-31
EP2932274B1 (en) 2020-01-15
WO2014090404A1 (en) 2014-06-19
EP2932274A1 (en) 2015-10-21
CA2893609A1 (en) 2014-06-19
US20200284806A1 (en) 2020-09-10
AU2013357812B2 (en) 2019-10-10
JP2016506501A (ja) 2016-03-03
IL239117A0 (en) 2015-07-30
AU2013357812A1 (en) 2015-05-28
BR112015013498A2 (pt) 2017-07-11
US10690682B2 (en) 2020-06-23
US20150316563A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
EA201590027A1 (ru) Способы детекции заболеваний или состояний
WO2013116769A8 (en) External files for distribution of molecular diagnostic tests and determination of compatibility between tests
WO2014201516A3 (en) Biomarker identification
WO2012106729A8 (en) System and method for evaluating an electrophysiological signal
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
EP3955004A3 (en) Use of fatty acids in methods for detecting cancer
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
AU2012339149A8 (en) Method for the diagnosis of Niemann-Pick disease
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
BR112012021590A2 (pt) detecção de capacitância em ensaio eletroquímico
GB201201766D0 (en) Method
WO2012107841A3 (en) Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof
GB2509682A (en) Biomarkers useful for detection of tyres, grades and stages of human breast cancer
GB201307566D0 (en) Method for detecting access of an object, computer thereof, and computer program
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
WO2014053996A3 (en) Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs
WO2012103260A3 (en) High-throughput methods to produce, validate and characterize mmabs
EA201401201A1 (ru) Способ
MX2015007494A (es) Metodo para diagnosticar leucodistrofia metacromatica.
WO2012070762A3 (ko) 컴퓨터 단층촬영장치를 이용한 지질시료 코어 내 이질물질 부피측정장치 및 그 방법
WO2014187884A3 (en) Mirnas as non-invasive biomarkers for heart failure
EP2752495B8 (en) Method for determining the activity of a proteolytic enzyme (variants), device for the implementation of same and diagnostic method